Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells

Journal of Experimental Medicine

Volumn 185, Issue 1, 1997, Pages 81-90

  Lazdins, Janis K ^a   Grell, Matthias ^b   Walker, Maja R ^a   Woods Cook, Kathie ^a   Scheurich, Peter ^b   Pfizenmaier, Klaus ^b  

^a Pharma Research   (Switzerland)

^b UNIVERSITY OF STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY PRODUCTION; ARTICLE; CELL DEATH; CHRONIC DISEASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIROGENESIS; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIGENS, CD; CELL DEATH; CELL LINE; CELL SURVIVAL; COCULTURE TECHNIQUES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HIV SERONEGATIVITY; HIV-1; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0031033929     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.1.81     Document Type: Article

References (58)

1. Folks, T.M., K.A. Clouse, J. Justement, A. Rabson, E. Duh, J.H. Kehrl, and A.S. Fauci. 1989. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA. 86:2365-2368.
2. Suzuki, M., N. Yamamoto, and F. Shmozaki. 1989. Augmentation of in vitro HIV replication in peripheral blood mononuclear cells of AIDS and ARC patients by tumor necrosis factor. Lancet. 1989:1206-1208.
3. Matsuyama, T., N. Kobayashi, and N. Yamamoto, 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS. 5:1405-1417.
4. Mellors, J.W., B.P. Griffith, M.A. Ortiz, M.L. Landry, and J.L. Ryan. 1991. Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages. J. Infect. Dis. 163:78-82.
5. Merrill, J.E., Y. Koyanagi, and I.S. Chen. 1989. Interleukin-1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol. 63:4404-4408.
6. Lahdevirta, J., C.P. Maury, A.M. Teppo, and H. Repo. 1988. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:289-291.
7. Fauci, A.S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science (Wash. DC). 262:1011-1018.
8. Matsuyama, T., Y. Hamamoto, S. Kobayashi, M. Kurimoto, J. Minowada, N. Kobayashi, and N. Yamamoto. 1988. Enhancement of human immunodeficiency virus production by natural lymphotoxin. Med. Microbiol. Immunol. (Berl). 177: 181-187.
9. Tartaglia, L.A., and D.V. Goeddel. 1992. Two TNF receptors. Immunol. Today. 13:151-153.
10. Smith, C.A., T. Farrah, and R.G. Goodwill. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 76:959-962.
11. Thoma, B., M. Grell, K. Pfizenmaier, and P. Scheurich. 1990. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses J. Exp. Med. 172:1019-1023.
12. Hohmann, H.P., M. Brockhaus, P.A. Baeuerle, R. Remy, R. Kolbeck, and A.P. van Loon. 1990. Expression of the types A and B tumor necrosis factor (TNF) receptors is independently regulated, and both receptors mediate activation of the transcription factor NF-kappa B. TNF alpha is not needed for induction of a biological effect via TNF receptors. J. Biol. Chem. 265:22409-22417.
13. Brockhaus, M., H.J. Schoenfeld, E.J. Schlaeger, W. Hunziker, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA. 87:3127-3131.
14. Engelmann, H., H. Hohmann, C. Brakebusch, Y.S. Avni, I. Sarov, Y. Nophar, E. Hadas, O. Leitner, and D. Wallach. 1990. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J. Biol. Chem. 265: 14497-14504.
15. Tartaglia, L.A., R.F. Weber, I.S. Figari, C. Reynolds, M.A. Palladino, Jr., and D.V. Goeddel. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA. 88:9292-9296.
16. Grell, M., G. Zimmermann, D. Hülser, K. Pfizenmaier, and P. Scheurich. 1994. TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J. Immunol. 153:1963-1972.
17. Tartaglia, L.A., D. Pennica, and D.V. Goeddel. 1993. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268:18542-18548.
18. Duh, E.J., W.J. Maury, T.M. Folks, A.S. Fauci, and A.B. Rabson. 1989. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA. 86:5974-5978.
19. Osborn, L., S. Kunkel, and G.J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. USA. 86:2336-2340.
20. Griffin, G.E., K. Leung, T.M. Folks, S. Kunkel, and G.J. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature (Lond.). 339:70-73.
21. Kaltschmidt, B., P. A. Baeuerle, and C. Kaltschmidt. 1993. Potential involvement of the transcription factor NF-kappa B in neurological disorders. Mol. Aspects. Med. 14:171-190.
22. Rattner, A., M.M. Korner, D. Walker, and Y. Citri. 1993. NF-kappa B activates the HIV promoter in neurons. EMBO (Eur. Mol. Biol. Organ.) J. 12:4261-4267.
23. Schütze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Krönke. 1992. TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell. 71:765-776.
24. Wiegmann, K., S. Schütze, E. Kampen, A. Himmler, T. Machleidt, and M. Krönke. 1992. Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J. Biol. Chem. 267:17997-18001.
25. Wiegmann, K., S. Schütze, T. Machleidt, D. Witte, and M. Krönke. 1994. Functional dichotomy of neutral and acidic sphmgomyelinases in tumor necrosis factor signaling. Cell 78:1005-1015.
26. Butera, S. T., B. D. Roberts, K. Leung, G. J. Nabel, and T. M. Folks. 1993. Tumor necrosis factor receptor expression and signal transduction in HIV-1-infected cells. AIDS. 7: 911-918.
27. Scheurich, P., M. Grell, A. Meager, and K. Pfizenmaier. 1993. Agonistic and antagonistic antibodies as a tool to study the functional role of human tumor necrosis factor receptors. In Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance. W. Fiers and W. Buurman, editors. S. Karger, Basel. 52-57.
28. McCune, J.M. 1995. Viral latency in HIV disease. Cell. 82: 183-188.
29. Poli, G., A. Kinter, J.S. Justement, J.H. Kehrl, P. Bressler, S. Stanley, and A.S. Fauci. 1990. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA. 87:782-785.
30. Howard, O.M., K.A. Clouse, C. Smith, R.G. Goodwin, and W.L. Farrar. 1993. Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation. Proc. Natl. Acad. Sci. USA. 90:2335-2339.
31. Grell, M., E. Douni, H. Wajant, M. Löhden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa TNF receptor. Cell. 83:793-802.
32. Clouse, K.A., D. Powell, I. Washington, G. Poli, K. Strebel, W. Farrar, P. Barstad, J. Kovacs, A.S. Fauci, and T.M. Folks. 1989. Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J. Immunol. 142:431-438.
33. Paleolog, E.M., S.A.J. Delasalle, W.A Buurman, and M. Feldmann. 1994. Functional activities of receptors for tumor necrosis factor alpha on human vascular endothelial cells. Blood. 84:2578-2582.
34. Grell, M., P. Scheurich, A. Meager, and K. Pfizenmaier. 1993. TR60 and TR80 tumor necrosis factor (TNF)-receptors can independently mediate cytolysis. Lymphokine Cytokine Res. 12:143-148.
35. Schols, D., R. Pauwels, F. Vanlangendonck, J. Balzarini, and E. De Clercq. 1988. A highly reliable, sensitive, flow cytometric/fluorometric assay for the evaluation of the anti-HIV activity of antiviral compounds in MT-4 cells. J. Immunol. Methods. 114:27-32.
36. Lazdins J.K., K. Woods-Cook, M. Walker, and E. Alteri. 1990. The lipophilic muramyl peptide MTP-PE is a potent inhibitor of HIV replication in macrophages. AIDS Res. Hum. Retroviruses. 6: 1157-1161.
37. Barre-Sinoussi, F., J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Venzinet-Brun, C. Rouzioux et al. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (Wash. DC). 220:868-871.
38. Ramachandra, S., and G.P. Studinski. 1995. Morphological and biochemical criteria of apoptosis. In Cell Growth and Apoptosis: A Practical Approach. G.P. Studinski, editor. Oxford University Press, UK. 119-142.
39. Idiorek, T., J. Estaquier, F. De Bels, and J.-C. Ameisen. 1995. YOPRO-1™ permits cytofluorometric detection of programmed cell death (apoptosis) without interfering with cell viability. J. Immun. Methods. 185:249-258.
40. Willey, R., D. Smith, T. Lasky, T. Theodore, P. Earl, B. Moss, D. Capon, and M. Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of human immunodeficiency virus that is critical for infectivity. J. Virol. 62:139-147.
41. Schmid, E., K. Binder, M. Grell, P. Scheurich, and K. Pfizenmaier. 1995. Both tumor necrosis factor receptors, TNFR60 and TNF80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha. Blood. 86:1836-1841.
42. Eissner, G., F. Kohlhuber, M. Grell, M. Ueffing, P. Scheurich, A. Hieke, G. Multhoff, G.W. Bornkamm, and E. Holler. 1995. Critical involvement of transmembrane TNF-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. Blood. 86:4184-4193.
43. Rothe, M., S.C. Wong, W.J. Henzel, and D.V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:681-692.
44. Rothe, M., V. Sarma, V.M. Dxit, and D.V. Goeddel. 1995. TRAF 2-mediated activation of NFκB by TNFR 2 and CD40. Science (Wash. DC). 269:1424-1427.
45. Hsu, H.L., H.B. Shu, M.G. Pan, and D.V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNFR1 signal transduction pathways. Cell. 84: 299-308.
46. Tartaglia, L.A., D.V. Goeddel, C. Reynolds, I.S. Figari, R.F. Weber, B.M. Fendly, and M.A. Palladino, Jr. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151: 4637-4641.
47. Grell, M. 1996. Tumor Necrosis Factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. J. Inflammation. 47:8-17.
48. Weiss, T., M. Grell, B. Hessabi, S. Bourtelee, G. Müller, P. Scheurich and H. Wajant. 1997. Enhancement of TNFR60-mediated cytotoxicity by TNFR80: requirement of the TRAF 2 binding site. J. Immunol. In press.
49. Birkland, T.P., J.P. Sypek, and D.J. Wyler. 1992. Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense. J. Leukoc. Biol. 51:296-299.
50. Aversa, G., J. Punnonen, and J.E. de Vries. 1993. The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation. J. Exp. Med. 177:1575-1585.
51. Lopez-Cepero, M., J.A. Garcia-Sanz, L. Herbert, R. Riley, M.E. Handel, E.R. Podack, and D.M. Lopez. 1994. Soluble and membrane-bound TNF-alpha are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets. J. Immunol. 152:3333-3341.
52. Zheng, L., G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M. Lenardo. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature (Lond.). 377:348-351.
53. Nii, A., S. Sone, E. Orino, and T. Ogura. 1993. Induction of a 26-kDa membrane-form tumor necrosis factor (TNF)-alpha in human alveolar macrophages. J. Leukoc. Biol. 53:29-36.
54. Liu, A.Y., E.P. Miskovsky, P.E. Stanhope, and R.F. Siliciano. 1992. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism. J. Immunol. 148:3789-3798.
55. Mohler, K.M., P.R. Sleath, J.N. Fitzner, D.P. Cerretti, M. Alderson, S.S. Kerwar, D.S. Torrance, C. Otten-Evans, T. Greenstreet, K. Weerawarna et al. 1994. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature (Lond.). 370:218-220.
56. McGeehan, G.M., J.D. Becherer, R.C. Bast, Jr., C.M. Boyer, B. Champion, K.M. Connolly, J.G. Conway, P. Furdon, S. Karp, S. Kidao et al. 1994. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature (Lond.). 370:558-561.
57. Gearing, A.J., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A.H. Davidson, A.H. Drummond, W.A. Galloway, R. Gilbert, J.L. Gordon et al. 1994. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature (Lond.). 370:555-557.
58. Crowe, P.D., B.N. Walter, K.M. Mohler, C. Otten-Evans, R.A. Black, and C.F. Ware. 1995. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J. Exp. Med. 181:1205-1210.